Shenghe Bioscience - B (02898.HK) announced its interim performance for the six months ending in June. Other income recorded RMB 1.78 million (same below), a 70.4% decrease from the previous year. The loss attributable to owners narrowed from RMB 61.49 million in the same period last year to RMB 36.08 million, with a loss per share of 34 cents. No interim dividend will be distributed.